Literature DB >> 3891962

Fate of porcine and human insulin at the subcutaneous injection site. I. Degradation and absorption of insulins in the rat.

K Okumura, F Komada, R Hori.   

Abstract

The plasma insulin and serum glucose levels were compared after the subcutaneous and intravenous administration of porcine and human insulin in rats. While no difference was observed in plasma insulin or serum glucose levels with either insulin after intravenous administration, the plasma insulin levels and hypoglycemic effects of human insulin were greater than those of porcine insulin after subcutaneous administration. At various time intervals, radioactivity in subcutaneous tissue was assayed for insulin and/or its metabolites by gel filtration. Using these data, the absorption and degradation rate constants of these substances were estimated according to a one-compartment model. The degradation rate constants of human insulin was approximately half of that for porcine insulin.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3891962     DOI: 10.1248/bpb1978.8.25

Source DB:  PubMed          Journal:  J Pharmacobiodyn        ISSN: 0386-846X


  7 in total

1.  Influence of absorption promoters on pulmonary insulin bioactivity.

Authors:  T Mahesh Kumar; Ambikanandan Misra
Journal:  AAPS PharmSciTech       Date:  2003       Impact factor: 3.246

2.  Modeling absorption kinetics of subcutaneous injected soluble insulin.

Authors:  E Mosekilde; K S Jensen; C Binder; S Pramming; B Thorsteinsson
Journal:  J Pharmacokinet Biopharm       Date:  1989-02

Review 3.  Proteolysis and Oxidation of Therapeutic Proteins After Intradermal or Subcutaneous Administration.

Authors:  Ninad Varkhede; Rupesh Bommana; Christian Schöneich; M Laird Forrest
Journal:  J Pharm Sci       Date:  2019-08-10       Impact factor: 3.534

4.  Facilitation of pulmonary insulin absorption by H-MAP: pharmacokinetics and pharmacodynamics in rats.

Authors:  S Suarez; L Garcia-Contreras; D Sarubbi; E Flanders; D O'Toole; J Smart; A J Hickey
Journal:  Pharm Res       Date:  2001-12       Impact factor: 4.200

5.  Enhanced bioavailability of subcutaneously injected insulin by pretreatment with ointment containing protease inhibitors.

Authors:  M Takeyama; T Ishida; N Kokubu; F Komada; S Iwakawa; K Okumura; R Hori
Journal:  Pharm Res       Date:  1991-01       Impact factor: 4.200

6.  Understanding the Monoclonal Antibody Disposition after Subcutaneous Administration using a Minimal Physiologically based Pharmacokinetic Model.

Authors:  Ninad Varkhede; Laird Forrest
Journal:  J Pharm Pharm Sci       Date:  2018       Impact factor: 2.327

7.  Enhanced bioavailability of subcutaneously injected insulin coadministered with collagen in rats and humans.

Authors:  R Hori; F Komada; S Iwakawa; Y Seino; K Okumura
Journal:  Pharm Res       Date:  1989-09       Impact factor: 4.200

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.